COVID-19 Research on Spike Proteins

COVID-19 happens and in April of 2020,

two researchers in Paris, France say, they said,

we're going to do a research study.

We want to order,

not a joke, it's in the paper.

We ordered spike proteins of COVID in April of 2020.

And they ordered them from two countries,

China and the UK.

And they said, we want to see

what their genetic makeup is.

What are they identical to in nature?

Is there anything in nature they look like?

So they said they put the two vials of proteins,

the two different proteins found on the COVID-19 virus,

and they put it into a DNA machine.

And then the DNA machine analyzes the amino acid sequence

in order of these proteins and

then publishes it on a piece of paper

and then publishes what they're identical to.

And they show you in the research study,

what they're identical to.

They said they're identical to two snake venom proteins

called the cobra toxin from the king cobra

and from the crate snake in China called bungaroo toxin.

Both of these venom proteins,

when you looked them up in research papers,

what do they do in a human or in a mammal?

They're both classified as neurotoxins,

meaning they only affect nerves.